- Oncology in Clinical Practice
- Search Author Details
Author Details
Radecka, Barbara
-
Vol 7, Supp. A (2011) - CASE REPORT
Kontrowersje dotyczące radiologicznej oceny odpowiedzi na leczenie u chorej na rozsianego raka piersi z nadmierną ekspresją HER2 leczonej lapatynibem z kapecytabiną — rola współpracy radiologa i klinicysty
Details PDF (Polish) -
Vol 7, Supp. C (2011) - CASE REPORT
Zastosowanie ewerolimusu w czwartej linii leczenia u chorego z zaawansowanym rakiem nerki
Abstract PDF (Polish) -
Vol 7, Supp. C (2011) - CASE REPORT
Zastosowanie ewerolimusu w trzeciej lini leczenia u chorego z zaawansowanym rakiem nerki
Abstract PDF (Polish) -
Vol 8, No 2 (2012) - REVIEW ARTICLES
Patients compliance, adherence and persistance is associated with effectiveness of oral therapies
Abstract PDF (Polish) -
Vol 10, No 3 (2014) - CASE REPORTS
Small cell lung cancer — case report
Abstract PDF (Polish) -
Vol 10, Supp. C (2014) - CASE REPORT
Complete response during treatment with abiraterone in castration-resistant prostate cancer — case report
Abstract PDF (Polish) -
Vol 12, No 6 (2016) - ORIGINAL ARTICLES
Carcinoembryonic antigen assessment during the perioperative period in patients with colorectal cancer in Poland
Abstract PDF -
Vol 15, No 2 (2019) - ORIGINAL ARTICLE
Consistency in biomarkers expression between matched tissue microarray cores from primary gallblader and ovarian cancers
Abstract PDF -
Vol 16, No 2 (2020) - STANOWISKO EKSPERTÓW (EXPERTS' OPINION)
Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic — comprehensive recommendations of the Polish Society of Clinical Oncology
Details PDF -
Vol 17, No 1 (2021) - CASE REPORT
Invasive breast cancer in ectopic axillary breast tissue — case report
Abstract PDF -
Vol 17, No 2 (2021) - REVIEW ARTICLES
Quality of life of patients with advanced pancreatic cancer
Abstract PDF -
Vol 18, No 3 (2022) - COMMENTARY
Commentary to Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results
Details PDF HTML -
Vol 19, No 4 (2023) - ORIGINAL ARTICLES
Chemotherapy compliance in elderly patients with solid tumors: a real-world clinical practice data
Abstract PDF HTML -
Vol 19, No 1 (2023) - CASE REPORTS
Stevens-Johnson syndrome in breast cancer patient treated with ribociclib
Abstract PDF HTML -
Vol 18, No 5 (2022) - REVIEW ARTICLES
Advanced pancreatic cancer: diagnosis and systemic treatment evolution over the last decades
Abstract PDF HTML -
Vol 19, No 6 (2023) - ORIGINAL ARTICLES
Survival of pancreatic cancer patients treated with nab-paclitaxel (nab-P) in clinical practice: analysis of National Health Fund data
Abstract PDF HTML -
Vol 20, No 2 (2024) - ORIGINAL ARTICLES
Home-based treatment with subcutaneous trastuzumab: safe and acceptable not only during a pandemic — final analysis of the RWD project ‘FlexCare’
Abstract PDF -
Vol 19, No 3 (2023) - REVIEW ARTICLES
Immunotherapy for gastroesophageal cancer
Abstract PDF HTML -
Vol 19, No 3 (2023) - REVIEW ARTICLES
Immunotherapy for colorectal cancer
Abstract PDF HTML -
Ahead of print - COMMENTARY
Commentary on Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience
Details PDF -
Ahead of print - ORIGINAL ARTICLES
Systemic treatment of patients with advanced pancreatic cancer — is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers
Abstract PDF -
Ahead of print - ORIGINAL ARTICLES
Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy
Abstract PDF -
Ahead of print - ORIGINAL ARTICLES
Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience
Abstract PDF
Important: This website uses cookies. More >>
The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.
Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl